The Clínic Barcelona Comprehensive Cancer Centre (4CB) has appointed Dr Susana Puig as Director of Research and Dr Teresa Macarulla as Director of...
Dr. Miquel Lozano Molero has been appointed President of the World Apheresis Association (WAA) for the 2026–2028 term. The election took place duri...
Developed by Clínic-IDIBAPS teams as part of the Clínic Barcelona Comprehensive Cancer Centre, this treatment confirms its therapeutic potential in...
Apheresis is a medical procedure by which specific components of a person’s blood are removed and the rest is returned to the bloodstream through o...
The creation of the Clínic Barcelona Comprehensive Cancer Center represents a step forward in the integration of care, clinical research, translati...
This year, FERO will contribute €200,000, with which it will seek to provide structural and sustained support for the Molecular Diagnostics Program...
Diseases such as stroke, heart attack or pulmonary embolism are mostly the consequence of a thrombosis; that is, a blood clot, which normally forms...
Following dietary recommendations, taking vitamin K regularly and treatment with an anticoagulant, such as Sintrom (acenocoumarol), are all importa...
The call for the presentation of applications for the I Estella Matutes Extraordinary Scholarship is open from September 19th to November 30th.
The Apheresis Unit, established in 1980, and which recently opened a new room, has achieved this milestone for the first time since its creation.
